Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Lung cancer, Non small cell lung cancer (NSCLC)
Closed
Phase 3
This trial is looking at osimertinib after surgery for non small cell lung cancer (NSCLC).
It is for people who have:
a small early cancer (stage 1A NSCLC)
had surgery or have surgery planned to remove the cancer
changes to genes affecting a protein called
Recruitment start: 6 April 2022
Recruitment end: 23 August 2024
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Laura Cove-Smith
AstraZeneca
Last reviewed: 26 August 2024
CRUK internal database number: 18121
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
